Literature DB >> 10357995

Fertility drugs and the risk of breast cancer.

E Ricci1, F Parazzini, E Negri, S Marsico, C La Vecchia.   

Abstract

Several studies have investigated the possible relationship between fertility drugs and the risk of breast cancer. To provide further information on this issue, we analysed data from a case control study, conducted in Northern Italy between 1983 and 1991. Trained interviewers identified and questioned 3415 cases (women aged 23-74 years with histologically confirmed breast cancer) and 2916 controls (women aged 21-74 years admitted to the same hospitals for diseases other than malignant, hormonal or gynaecological conditions). Fifty (1.5%) cases and 53 (1.8%) controls reported any history of infertility; the corresponding multivariate odds ratios (OR) of breast cancer was 0.8 [95% confidence interval (CI) 0.5-1.1]. Sixteen (0.5%) cases and 11 (0.4%) controls reported ever using fertility drugs; the corresponding OR was 1.2 (95% CI 0.5-2.6). Allowance for potential confounding factors did not markedly modify these estimates. In conclusion, this study provides reassuring evidence on the absence of an association between fertility drug treatment and breast cancer risk.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10357995     DOI: 10.1093/humrep/14.6.1653

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  7 in total

1.  Fertility drugs and young-onset breast cancer: results from the Two Sister Study.

Authors:  Chunyuan Fei; Lisa A Deroo; Dale P Sandler; Clarice R Weinberg
Journal:  J Natl Cancer Inst       Date:  2012-07-06       Impact factor: 13.506

2.  Fertility drugs and the risk of breast and gynecologic cancers.

Authors:  Louise A Brinton; Vikrant V Sahasrabuddhe; Bert Scoccia
Journal:  Semin Reprod Med       Date:  2012-04-27       Impact factor: 1.303

3.  Fertility drug use and mammographic breast density in a mammography screening cohort of premenopausal women.

Authors:  Brian L Sprague; Amy Trentham-Dietz; Mary Beth Terry; Hazel B Nichols; Andrew J Bersch; Diana S M Buist
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

4.  The effect of assisted reproductive technologies on gynecological cancer: report of our experiences and literature review.

Authors:  Mojgan Karimi Zarchi; Mitra Rouhi; Alime H Abdolahi; Seyedhossein Hekmatimoghaddam
Journal:  Int J Biomed Sci       Date:  2013-09

5.  Cytochrome P-450 1B1 Leu432Val Polymorphism Does Not Show Association With Breast Cancer in Northern Iranian Women With a History of Infertility.

Authors:  Maryam Ghanbari Andarieh; Ebrahim Zabihi; Dariush Moslemi; Mouloud Agajani Delavar; Mahmoud Haji-Ahmadi; Ali Shabestani Monfared; Seyed Gholam Ali Jorsaraei; Masoumeh Ghasemi; Sedighe Esmaeilzadeh
Journal:  Biomark Insights       Date:  2017-02-20

Review 6.  Do the Fertility Drugs Increase the Risk of Cancer? A Review Study.

Authors:  Zohre Momenimovahed; Safoura Taheri; Azita Tiznobaik; Hamid Salehiniya
Journal:  Front Endocrinol (Lausanne)       Date:  2019-05-24       Impact factor: 5.555

7.  Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort.

Authors:  I dos Santos Silva; P A Wark; V A McCormack; D Mayer; C Overton; V Little; J Nieto; P Hardiman; M Davies; A B MacLean
Journal:  Br J Cancer       Date:  2009-05-12       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.